Search
for
Sort by
Research 211–240 of 1000+
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Obesity and polycystic ovary syndrome
- Depression, anxiety and perceived stress in women with and without PCOS: a community-based study
- Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Insulin Resistance and Skin Diseases
- PCOS in adolescents
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- 5α-Reduced glucocorticoids: a story of natural selection
- Acne in the adult female patient: a practical approach
- Evidence-based approach to cutaneous hyperandrogenism in women
- A Mouse Model of Androgenetic Alopecia
- Hirsutism: Diagnosis and management
- Polycystic ovary syndrome (PCOS)
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Gender-Affirming Hormone Therapy for Transgender Men
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight